JP2010526090A - 癌の治療のための方法および組成物 - Google Patents

癌の治療のための方法および組成物 Download PDF

Info

Publication number
JP2010526090A
JP2010526090A JP2010506618A JP2010506618A JP2010526090A JP 2010526090 A JP2010526090 A JP 2010526090A JP 2010506618 A JP2010506618 A JP 2010506618A JP 2010506618 A JP2010506618 A JP 2010506618A JP 2010526090 A JP2010526090 A JP 2010526090A
Authority
JP
Japan
Prior art keywords
seq
mesd
sequence
lrp6
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010506618A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526090A5 (enExample
Inventor
グオジュン・ブ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington University in St Louis WUSTL
Original Assignee
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Washington University in St Louis WUSTL filed Critical Washington University in St Louis WUSTL
Publication of JP2010526090A publication Critical patent/JP2010526090A/ja
Publication of JP2010526090A5 publication Critical patent/JP2010526090A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2010506618A 2007-04-30 2008-04-30 癌の治療のための方法および組成物 Pending JP2010526090A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91490207P 2007-04-30 2007-04-30
PCT/US2008/062092 WO2008134752A2 (en) 2007-04-30 2008-04-30 Methods and compositions for the treatment of cancer

Publications (2)

Publication Number Publication Date
JP2010526090A true JP2010526090A (ja) 2010-07-29
JP2010526090A5 JP2010526090A5 (enExample) 2011-01-06

Family

ID=39926323

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010506618A Pending JP2010526090A (ja) 2007-04-30 2008-04-30 癌の治療のための方法および組成物

Country Status (7)

Country Link
US (1) US8198236B2 (enExample)
EP (1) EP2150270A4 (enExample)
JP (1) JP2010526090A (enExample)
AU (1) AU2008245425A1 (enExample)
BR (1) BRPI0810207A2 (enExample)
CA (1) CA2685737A1 (enExample)
WO (1) WO2008134752A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017008060A (ja) * 2010-05-06 2017-01-12 ノバルティス アーゲー 治療的低密度リポタンパク質関連タンパク質６（ｌｒｐ６）抗体の組成物および使用方法
WO2020122655A1 (ko) * 2018-12-13 2020-06-18 주식회사 엘베이스 올리고펩티드를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080227698A1 (en) * 2005-11-08 2008-09-18 Washington University Oligopeptides for treatment of osteoporosis and other bone diseases and methods thereof
EP2427490A1 (en) * 2009-05-07 2012-03-14 Novartis AG Compositions and methods of use for binding molecules to dickkopf-1 or dickkopf-4 or both
KR20140091031A (ko) 2011-11-04 2014-07-18 노파르티스 아게 저밀도 지단백질-관련 단백질 6 (lrp6) - 반감기 연장제 구축물
WO2014109519A1 (ko) * 2013-01-10 2014-07-17 강원대학교산학협력단 작은안구증-연관 전사인자 유래의 펩타이드 및 이를 포함하는 조성물
EP3265112B1 (en) * 2015-01-19 2025-12-24 Technion Research & Development Foundation Limited Ubiquitin ligase kpc1 and p50 for use in the treatment of cancer
CN114853847B (zh) 2022-06-29 2022-09-27 中国农业大学 辣椒籽分离的寡肽ftle及其在预防或治疗癌症中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005115354A2 (en) * 2004-05-19 2005-12-08 Enzo Therapeutics, Inc. Compositions and methods for bone formation and remodeling

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104538A1 (en) * 1997-09-18 2003-06-05 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU1918601A (en) * 1999-11-19 2001-05-30 Human Genome Sciences, Inc. 23 human secreted proteins
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
US20080227698A1 (en) * 2005-11-08 2008-09-18 Washington University Oligopeptides for treatment of osteoporosis and other bone diseases and methods thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005115354A2 (en) * 2004-05-19 2005-12-08 Enzo Therapeutics, Inc. Compositions and methods for bone formation and remodeling

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6012045393; Ｊ．Ｃｅｌｌ　Ｓｃｉ．，　２００５，　Ｖｏｌ．　１１８，　Ｎｏ．　２２，　Ｐ．　５３０５-５３１４ *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017008060A (ja) * 2010-05-06 2017-01-12 ノバルティス アーゲー 治療的低密度リポタンパク質関連タンパク質６（ｌｒｐ６）抗体の組成物および使用方法
WO2020122655A1 (ko) * 2018-12-13 2020-06-18 주식회사 엘베이스 올리고펩티드를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물
CN113164554A (zh) * 2018-12-13 2021-07-23 L 基础有限公司 包含寡肽作为活性成分的用于预防或治疗癌症的药物组合物
US12048730B2 (en) 2018-12-13 2024-07-30 L-Base Co., Ltd. Pharmaceutical composition for preventing or treating cancer, containing oligopeptide as active ingredient

Also Published As

Publication number Publication date
WO2008134752A2 (en) 2008-11-06
US8198236B2 (en) 2012-06-12
AU2008245425A1 (en) 2008-11-06
BRPI0810207A2 (pt) 2014-10-14
EP2150270A2 (en) 2010-02-10
US20100120685A1 (en) 2010-05-13
EP2150270A4 (en) 2011-09-28
WO2008134752A3 (en) 2008-12-24
CA2685737A1 (en) 2008-11-06
AU2008245425A2 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
AU2008245425A1 (en) Methods and compositions for the treatment of cancer
AU2015205918A1 (en) Methods for increasing thermogenic adipocytes
RU2012151205A (ru) Модифицированные связывающие белки, ингибирующие взаимодействие vegf-a рецептора
DK2282728T3 (en) Modulation at Vps10p domain receptors
US20070059829A1 (en) Cristin/R-spondin ligands active in the Wnt signaling pathway and methods, compositions and kits relating thereto
US8603455B2 (en) Removal promoters and inhibitor for apoptosis cells in vivo
CA2331332A1 (en) Anti-angiogenic proteins and methods of use thereof
US7504374B2 (en) Method for inducing deposition and maturation of bone comprising a co-therapeutic regimen of LMP-1 and BMP-2
US20110033516A1 (en) Methods and compositions for bone healing by periostin
US20050147602A1 (en) Compositions, methods and kits relating to CTHRC1, a novel modulator of collagen matrix
JP2002537270A (ja) 止血及び免疫機能における使用のためのインヒビター
Xu et al. Analysis of molecular domains of epitope-tagged merlin isoforms in Cos-7 cells and primary rat Schwann cells
WO2002042487A2 (en) Compositions, methods and kits relating to remodelin
JP2008013436A (ja) 血管形成促進剤
WO2024014463A1 (ja) 腎臓結石の治療または予防剤
JP2017538683A (ja) 抗血管形成薬としてのオリゴペプチド体
US20040106549A1 (en) Anti-angiogenic proteins and methods of use thereof
US20080227698A1 (en) Oligopeptides for treatment of osteoporosis and other bone diseases and methods thereof
AU2006226993B2 (en) Mechanisms of osteoinduction by LIM mineralization protein-1 (LMP-1)
JP4843595B2 (ja) 生体内のアポトーシス細胞の除去促進剤及び除去阻害剤
CN101115839B (zh) 通过rh核心蛋白聚糖-Fc融合蛋白抑制纤维发生的方法
Simons Syndecan-4 Clustering Induces Cell Migration in a PDZ-Dependent Manner
WO2005079859A1 (ja) 標的指向性運搬体
KR20140145460A (ko) 글루코사민을 포함한 조성물 및 그의 용도

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101109

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101109

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20120309

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120904

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121225

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130730